FDA recall D-1065-2016
Allergan Sales, LLC · Class II · drug
Product
Tazorac (tazarotene) Gel 0.05%, 15 x 3.5g, sample packs, Allergan Inc, Irvine, CA 92612. UPC 300238335159
Reason for recall
Failed Content Uniformity Specifications.
Distribution
Nationwide and Puerto Rico
Key facts
- Status
- Terminated
- Initiation date
- 2016-05-10
- Report date
- 2016-07-13
- Termination date
- 2017-12-06
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Waco, TX, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1065-2016